JOHNSON & JOHNSON

Company Snapshot

Founded: 1886
Entity Type: Public
Employees: 138,200
Region: United States
Revenue: $94,193 Millions
Revenue Year: 2025
Segment: Innovative Medicine
Headquarter: New Jersey, U.S.
Key Geographics: U.S., Europe, Asia-Pacific, Africa
Corporate Address: One Johnson & Johnson Plaza New Brunswick New Jersey, 08933 U.S. Tel. 732-524-0400 www.jnj.com

Company Overview

Johnson & Johnson is involved in the research, development, manufacturing, and sale of pharmaceuticals and medical devices. In September 2022, Johnson & Johnson renamed its consumer health division Kenvue and announced plans to spin off the unit. In May 2023, Kenvue went public on the New York Stock Exchange, trading under the ticker symbol KVUE.

After the consumer health business split, Johnson & Johnson Services Inc. is organized into two segments: Innovative Medicine and MedTech. The MedTech segment (formerly known as Medical Devices) includes a wide range of products used in Interventional Solutions, Orthopedics, Surgery, and Vision categories.

Johnson & Johnson Innovative Medicine (formerly Janssen Pharmaceutical Companies) offers diverse portfolios across multiple therapeutic areas: Oncology, Immunology, Neuroscience, Cardiovascular, Pulmonary Hypertension, and Retina. It is a leading provider of gastroenterology drugs, including IBD therapies. It markets its products in over 175 countries and has approximately 138,100 employees worldwide.

Financial Highlights (FY 2025)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

JOHNSON & JOHNSON In Reports

Global Implantable Medical Devices Market

Explore the implantable medical devices market, covering pacemakers, orthopedic implants, neurostimulators, and advances in long-term patient care.

Global Renal Disease Treatments: Products and Therapies

Discover insights into the global renal disease treatments market, including product types, disease segments, dialysis, transplantation, end users and competitive dynamics through 2031.

Pharmaceutical Treatments for Mental Health Disorders: Global Markets

Analyse the global mental health disorders pharmaceuticals market by drug type, condition and region with competitive insights and forecasts through 2030.

Company's Business Segments

  • Innovative Medicine : Immunology, Neuroscience, Infectious Diseases, Cardiovascular and Metabolism, Pulmonary Hypertension.
  • MedTech : MEdTech segment inclues Surgery, Orthopaedics, Interventional Solutions, Vision

Applications/End User Industries

  • Surgeons
  • Orthopedic Specialists
  • Ophthalmologists
  • General Surgeons
  • Orthopedic Surgeons
  • Cardiothoracic Surgeons
  • Neurosurgeons
  • Pulmonary Arterial Hypertension
  • Gynecologists
  • Obstetricians
  • Rheumatologists
  • Pediatricians
  • Hematologists
  • Pain Management Specialists
  • Immunology-Related Medications
  • Biologic Therapies
  • Antifungal Medications
  • Cardiovascular Diseases
  • Dermatologists
AI Sentiment